Carregant...

In vitro and in vivo activities of clarithromycin against Mycobacterium avium.

There is no effective therapy to treat Mycobacterium avium complex infection in patients with acquired immune deficiency syndrome. Clarithromycin (A-56268; TE-031) is a new macrolide which is twofold more active than erythromycin against most aerobic bacteria. In addition, higher levels in serum and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fernandes, P B, Hardy, D J, McDaniel, D, Hanson, C W, Swanson, R N
Format: Artigo
Idioma:Inglês
Publicat: 1989
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC172696/
https://ncbi.nlm.nih.gov/pubmed/2530933
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!